Last $141.34 USD
Change Today -2.67 / -1.85%
Volume 1.6M
AMGN On Other Exchanges
Symbol
Exchange
Hong Kong
Mexico
NASDAQ GS
Sao Paulo
Frankfurt
As of 2:30 PM 09/22/14 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Richard D. Nanula

Former Chief Financial Officer, Executive Vice President of Finance and Executive Vice President of Strategy & Communications, Amgen Inc.
AgeTotal Calculated CompensationThis person is connected to 36 board members in 2 different organizations across 8 different industries.

See Board Relationships
53--

Background*

Mr. Richard D. Nanula serves as Chairman of LodgeNet Interactive Corporation. He was a Principal at Colony Capital, LLC. Mr. Nanula joined Colony Capital on January 8, 2008. Mr. Nanula was an Executive Vice President, Finance, Strategy, & Communications at Amgen Inc. At Amgen, he was the Executive Vice President since May 2001 and the Chief Financial Officer since August 2001. He joined Amgen in 2001. From November 1999 to February 2001, Mr. Nanula served as the Chairman ...

Read Full Background

Corporate Headquarters*

One Amgen Center Drive
Thousand Oaks, California 91320

United States

Phone: 805-447-1000
Fax: 805-447-1010

Board Members Memberships*

Director
Chairman
Trustee
Chairman
Former Board Member
1999-N/A
Former Chairman of the Board and Chief Executive Officer
2005-2007
Former Independent Director, Member of Audit Committee, Member of Special Programs Committee and Member of Finance Committee

Education*

MBA 1986
Harvard University
BA 1982
University of California, Santa Barbara

Other Affiliations*

Annual Compensation*

There is no Annual Compensation data available.

Stock Options*

There is no Stock Options data available.

Total Compensation*

There is no Total Compensation data available.
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
AMGN:US $141.38 USD -2.63

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
John C. Martin Ph.D.Chairman and Chief Executive Officer
Gilead Sciences Inc.
$1.6M
Inge G. Thulin Chairman, Chief Executive Officer and President
3M Company
$1.3M
Erez Vigodman Chief Executive Officer, President, Director, Member of Audit Committee and Member of Finance & Invesment Committee
Teva Pharmaceutical Industries Limited
--
Lars Rebien Sørensen Chief Executive Officer
Novo Nordisk A/S
kr15.2M
Richard A. Gonzalez Chairman, Chief Executive Officer and Chairman of Executive Committee
AbbVie Inc.
$1.5M
Compensation as of Fiscal Year 2013.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact AMGEN INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.